chlormadinone acetate has been researched along with Bone Loss, Osteoclastic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akakura, K; Akimoto, S; Furuya, Y; Inomiya, H; Ito, H | 1 |
1 other study(ies) available for chlormadinone acetate and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Prognostic value of the serum levels of bone formation and bone resorption markers in prostate cancer patients with bone metastasis.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Biomarkers, Tumor; Bone Neoplasms; Bone Resorption; Chlormadinone Acetate; Collagen; Collagen Type I; Estrogens; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Orchiectomy; Peptide Fragments; Peptides; Procollagen; Progesterone Congeners; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms | 1998 |